INEO NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

INNEOVA Holdings Limited · Consumer Cyclical · Auto Parts

Open interactive chart View report data
Latest close 0.60 USD
-16.1% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 1.1% above the Trend Line and sits at 34.0% of its 52-week range. The latest completed week returned -16.1%, after a -10.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 20d.

Setup score 40 out of 100
Latest Close 0.60 USD 31 Jul 2026
1W Return -16.1% latest completed week
4W Return -10.5% short-term follow-through
12W Return 4.7% quarterly tape
Trend Breadth 17.1% 6 of 35 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 6-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -16.1% Latest completed week; four-week move -10.5%. Indicator stack 30/67 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 71.01% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 38 relevant articles in the latest sentiment read. Event risk 20d Next report is scheduled for 21 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 1.1% above the Trend Line and sits at 34.0% of its 52-week range. The latest completed week returned -16.1%, after a -10.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4612-week average 0.24

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.46Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -10.5% over four weeks, 4.7% over 12 weeks, and - over one year. The current trend has remained active for 6 consecutive weeks.

Performance by holding period

1W-16.1%
4W-10.5%
12W4.7%
26W-1.5%
52W-
Active trend streak6 weeks
Active weeks in one year6
Trend breadth17.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.80Latest activity-pressure read.
Pressure change34.6%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength58/100Blend of value, momentum, and quality. Underlying universe rank 43; rank 1 is best.
Value53/100Relative valuation strength. Underlying universe rank 48; rank 1 is best.
Quality51/100Profitability and accounting quality. Underlying universe rank 50; rank 1 is best.
Momentum53/100Medium-term price momentum. Underlying universe rank 48; rank 1 is best.
Growth53/100Revenue and earnings growth. Underlying universe rank 48; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.2x
Market value relative to trailing revenue.
EV / EBITDA
27.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
14.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
19.2%
Gross profit retained from each unit of revenue.
Operating margin
0.5%
Operating profit retained from revenue.
Free-cash-flow margin
7.6%
Free cash flow generated from revenue.
Return on invested capital
0.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
16.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 38 relevant articles.

9 positive · 23 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings20dNext report is scheduled for 21 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-34.1%Distance below the 52-week high.
13-week volatility9.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+45.3%Week of 27 Feb.
Worst week-29.9%Week of 6 Mar.
Latest week-16.1%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains4
Flat weeks0
Modest losses5
Sharp losses8
Recent vol9.0%13-week weekly-return volatility.
Base vol14.3%52-week weekly-return volatility.
Up/down split17/17Count of positive and negative weeks in the 52-week window.
Average skew11.0% / -9.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape43/100

Trend, activity pressure, participation, and risk combine to a 43/100 tape read.

 Indicator analysis42/100

Latest 12-week confirmation: trend 6/12, activity pressure 7/12, relative leadership 0/12.

Activity pressure 0.46; No reversal markers Next-Week ExpectancyPositive 71.01%

Next-week expectancy is positive with a 71.01% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors53/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 49 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 38 relevant articles.

INEO|Inneova Holdings Ord Shs|Price:0.629|Chg%:-0.011 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings20d

Next report is scheduled for 21 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20260.60 USD-16.1%0.59 USD0.59 USD0.80-407.1KOn
24 Jul 20260.72 USD4.8%0.59 USD0.59 USD0.90-2.0MOn
17 Jul 20260.68 USD-2.5%0.59 USD0.59 USD0.79-1.9MOn
10 Jul 20260.70 USD4.5%0.58 USD0.59 USD0.64-148.9KOn
3 Jul 20260.67 USD15.0%0.58 USD0.58 USD0.60-369.4KOn
26 Jun 20260.58 USD2.2%0.58 USD0.58 USD0.42-42.1KOn
19 Jun 20260.57 USD-9.5%-0.58 USD0.32-232.9KOff
12 Jun 20260.63 USD14.5%-0.58 USD--1.1MOff
5 Jun 20260.55 USD-2.6%-0.58 USD--462.1KOff
29 May 20260.56 USD-10.3%-0.58 USD--406.4KOff
22 May 20260.63 USD-0.6%-0.58 USD--343.4KOff
15 May 20260.63 USD10.6%-0.58 USD--489.8KOff
8 May 20260.57 USD0.9%-0.57 USD--234.0KOff
1 May 20260.57 USD-24.1%-0.57 USD--885.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.